TickerFactsScreenerDevelopers

Xenon Pharmaceuticals Inc. (XENE) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2017: -$28.73M2018: -$34.72M2019: -$4.71M2020: -$48.12M2021: -$69.50M2022: -$101.03M2023: -$151.11M2024: -$181.39M2025: -$279.12M-$279.12M
2017Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$279.12M-53.9%
2024-$181.39M-20.0%
2023-$151.11M-49.6%
2022-$101.03M-45.4%
2021-$69.50M-44.4%
2020-$48.12M-920.9%
2019-$4.71M+86.4%
2018-$34.72M-20.9%
2017-$28.73M—